
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="ABCBA84E9264D2633DA84E001AD1C6CC.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="ijms">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7312854/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="International Journal of Molecular Sciences">
<meta name="citation_title" content="Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide">
<meta name="citation_author" content="Yosuke Hirotsu">
<meta name="citation_author_institution" content="Genome Analysis Center, Yamanashi Central Hospital, Kofu 400-8506, Japan; m-omata0901@ych.pref.yamanashi.jp or">
<meta name="citation_author" content="Udo Schmidt-Edelkraut">
<meta name="citation_author_institution" content="Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)">
<meta name="citation_author" content="Hiroshi Nakagomi">
<meta name="citation_author_institution" content="Department of Breast Surgery, Yamanashi Central Hospital, Kofu 400-8506, Japan; h-nakagomi@ych.pref.yamanashi.jp">
<meta name="citation_author" content="Ikuko Sakamoto">
<meta name="citation_author_institution" content="Department of Obstetrics and Gynecology, Yamanashi Central Hospital, Kofu 400-8506, Japan; i-nagata@ych.pref.yamanashi.jp">
<meta name="citation_author" content="Markus Hartenfeller">
<meta name="citation_author_institution" content="Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)">
<meta name="citation_author" content="Ram Narang">
<meta name="citation_author_institution" content="Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)">
<meta name="citation_author" content="Theodoros G Soldatos">
<meta name="citation_author_institution" content="Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)">
<meta name="citation_author" content="Sajo Kaduthanam">
<meta name="citation_author_institution" content="Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)">
<meta name="citation_author" content="Xiaoyue Wang">
<meta name="citation_author_institution" content="Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)">
<meta name="citation_author" content="Stephan Hettich">
<meta name="citation_author_institution" content="Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)">
<meta name="citation_author" content="Stephan Brock">
<meta name="citation_author_institution" content="Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)">
<meta name="citation_author" content="David B Jackson">
<meta name="citation_author_institution" content="Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)">
<meta name="citation_author" content="Masao Omata">
<meta name="citation_author_institution" content="Genome Analysis Center, Yamanashi Central Hospital, Kofu 400-8506, Japan; m-omata0901@ych.pref.yamanashi.jp or">
<meta name="citation_author_institution" content="University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan">
<meta name="citation_publication_date" content="2020 May 29">
<meta name="citation_volume" content="21">
<meta name="citation_issue" content="11">
<meta name="citation_firstpage" content="3895">
<meta name="citation_doi" content="10.3390/ijms21113895">
<meta name="citation_pmid" content="32486089">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7312854/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7312854/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7312854/pdf/ijms-21-03895.pdf">
<meta name="description" content="BRCA1/2 variants are prognostic biomarkers for hereditary breast and/or ovarian cancer (HBOC) syndrome and predictive biomarkers for PARP inhibition. In this study, we benchmarked the classification of BRCA1/2 variants from patients with ...">
<meta name="og:title" content="Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="BRCA1/2 variants are prognostic biomarkers for hereditary breast and/or ovarian cancer (HBOC) syndrome and predictive biomarkers for PARP inhibition. In this study, we benchmarked the classification of BRCA1/2 variants from patients with ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7312854/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="7312854">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3390/ijms21113895"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/ijms-21-03895.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7312854%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/7312854/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/7312854/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7312854/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-ijms.png" alt="International Journal of Molecular Sciences logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to International Journal of Molecular Sciences" title="Link to International Journal of Molecular Sciences" shape="default" href="http://www.mdpi.com/journal/ijms/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Int J Mol Sci</button></div>. 2020 May 29;21(11):3895. doi: <a href="https://doi.org/10.3390/ijms21113895" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3390/ijms21113895</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Int%20J%20Mol%20Sci%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Int%20J%20Mol%20Sci%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Int%20J%20Mol%20Sci%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Int%20J%20Mol%20Sci%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Consolidated BRCA1/2 Variant Interpretation by MH BRCA Correlates with Predicted PARP Inhibitor Efficacy Association by MH Guide</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hirotsu%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yosuke Hirotsu</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yosuke Hirotsu</span></h3>
<div class="p">
<sup>1</sup>Genome Analysis Center, Yamanashi Central Hospital, Kofu 400-8506, Japan; m-omata0901@ych.pref.yamanashi.jp or </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hirotsu%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yosuke Hirotsu</span></a>
</div>
</div>
<sup>1,</sup><sup>*,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schmidt-Edelkraut%20U%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Udo Schmidt-Edelkraut</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Udo Schmidt-Edelkraut</span></h3>
<div class="p">
<sup>2</sup>Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schmidt-Edelkraut%20U%22%5BAuthor%5D" class="usa-link"><span class="name western">Udo Schmidt-Edelkraut</span></a>
</div>
</div>
<sup>2,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nakagomi%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Hiroshi Nakagomi</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Hiroshi Nakagomi</span></h3>
<div class="p">
<sup>3</sup>Department of Breast Surgery, Yamanashi Central Hospital, Kofu 400-8506, Japan; h-nakagomi@ych.pref.yamanashi.jp</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nakagomi%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hiroshi Nakagomi</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sakamoto%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Ikuko Sakamoto</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Ikuko Sakamoto</span></h3>
<div class="p">
<sup>4</sup>Department of Obstetrics and Gynecology, Yamanashi Central Hospital, Kofu 400-8506, Japan; i-nagata@ych.pref.yamanashi.jp</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sakamoto%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Ikuko Sakamoto</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hartenfeller%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Markus Hartenfeller</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Markus Hartenfeller</span></h3>
<div class="p">
<sup>2</sup>Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hartenfeller%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Markus Hartenfeller</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Narang%20R%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Ram Narang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Ram Narang</span></h3>
<div class="p">
<sup>2</sup>Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Narang%20R%22%5BAuthor%5D" class="usa-link"><span class="name western">Ram Narang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soldatos%20TG%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Theodoros G Soldatos</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Theodoros G Soldatos</span></h3>
<div class="p">
<sup>2</sup>Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Soldatos%20TG%22%5BAuthor%5D" class="usa-link"><span class="name western">Theodoros G Soldatos</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kaduthanam%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Sajo Kaduthanam</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Sajo Kaduthanam</span></h3>
<div class="p">
<sup>2</sup>Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kaduthanam%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sajo Kaduthanam</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Xiaoyue Wang</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Xiaoyue Wang</span></h3>
<div class="p">
<sup>2</sup>Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xiaoyue Wang</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hettich%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Stephan Hettich</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Stephan Hettich</span></h3>
<div class="p">
<sup>2</sup>Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hettich%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Stephan Hettich</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Brock%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Stephan Brock</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Stephan Brock</span></h3>
<div class="p">
<sup>2</sup>Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Brock%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Stephan Brock</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jackson%20DB%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">David B Jackson</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">David B Jackson</span></h3>
<div class="p">
<sup>2</sup>Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jackson%20DB%22%5BAuthor%5D" class="usa-link"><span class="name western">David B Jackson</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Omata%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Masao Omata</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Masao Omata</span></h3>
<div class="p">
<sup>1</sup>Genome Analysis Center, Yamanashi Central Hospital, Kofu 400-8506, Japan; m-omata0901@ych.pref.yamanashi.jp or </div>
<div class="p">
<sup>5</sup>University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Omata%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Masao Omata</span></a>
</div>
</div>
<sup>1,</sup><sup>5</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-ijms-21-03895">
<sup>1</sup>Genome Analysis Center, Yamanashi Central Hospital, Kofu 400-8506, Japan; m-omata0901@ych.pref.yamanashi.jp or </div>
<div id="af2-ijms-21-03895">
<sup>2</sup>Molecular Health GmbH, Research Department, 69115 Heidelberg, Germany; udo.schmidt-edelkraut@molecularhealth.com (U.S.-E.); markus.hartenfeller@molecularhealth.com (M.H.); ramnarang@gmx.de (R.N.); theodoros.soldatos@molecularhealth.com (T.G.S.); sajo.kaduthanam@gmx.de (S.K.); xiaoyue.wang@molecularhealth.com (X.W.); stephan.hettich@molecularhealth.com (S.H.); stephan.brock@molecularhealth.com (S.B.); david.jackson@molecularhealth.com (D.B.J.)</div>
<div id="af3-ijms-21-03895">
<sup>3</sup>Department of Breast Surgery, Yamanashi Central Hospital, Kofu 400-8506, Japan; h-nakagomi@ych.pref.yamanashi.jp</div>
<div id="af4-ijms-21-03895">
<sup>4</sup>Department of Obstetrics and Gynecology, Yamanashi Central Hospital, Kofu 400-8506, Japan; i-nagata@ych.pref.yamanashi.jp</div>
<div id="af5-ijms-21-03895">
<sup>5</sup>University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan</div>
<div class="author-notes p">
<div class="fn" id="c1-ijms-21-03895">
<sup>*</sup><p class="display-inline">Correspondence: <span>hirotsu-bdyu@ych.pref.yamanashi.jp</span>; Tel.: +81-55-253-7111</p>
</div>
<div class="fn" id="fn1-ijms-21-03895">
<sup>†</sup><p class="display-inline">These authors contributed equally to this work.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2020 Mar 30; Accepted 2020 May 29; Collection date 2020 Jun.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2020 by the authors.</div>
<p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="http://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC7312854  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32486089/" class="usa-link">32486089</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p><em>BRCA1/2</em> variants are prognostic biomarkers for hereditary breast and/or ovarian cancer (HBOC) syndrome and predictive biomarkers for PARP inhibition. In this study, we benchmarked the classification of <em>BRCA1/2</em> variants from patients with HBOC-related cancer using MH BRCA, a novel computational technology that combines the ACMG guidelines with expert-curated variant annotations. Evaluation of <em>BRCA1/2</em> variants (<em>n</em> = 1040) taken from four HBOC studies showed strong concordance within the pathogenic (98.1%) subset. Comparison of MH BRCA’s ACMG classification to ClinVar submitter content from ENIGMA, the international consortium of investigators on the clinical significance of <em>BRCA1/2</em> variants, the ARUP laboratories, a clinical testing lab of the University of UTAH, and the German Cancer Consortium showed 99.98% concordance (4975 out of 4976 variants) in the pathogenic subset. In our patient cohort, refinement of patients with variants of unknown significance reduced the uncertainty of cancer-predisposing syndromes by 64.7% and identified three cases with potential family risk to HBOC due to a likely pathogenic variant <em>BRCA1</em> p.V1653L (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.3</a>:c.4957G &gt; T; rs80357261). To assess whether classification results predict PARP inhibitor efficacy, contextualization with functional impact information on DNA repair activity were performed, using MH Guide. We found a strong correlation between treatment efficacy association and MH BRCA classifications. Importantly, low efficacy to PARP inhibition was predicted in 3.95% of pathogenic variants from four examined HBOC studies and our patient cohort, indicating the clinical relevance of the consolidated variant interpretation.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> <em>BRCA1</em>, <em>BRCA2</em>, PARP inhibition, HBOC, cancer</p></section></section><section id="sec1-ijms-21-03895"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Deleterious <em>BRCA1/2</em> variants have emerged as critical prognostic and predictive biomarkers for deficiency in DNA damage repair by the homologous recombination (HR) machinery [<a href="#B1-ijms-21-03895" class="usa-link" aria-describedby="B1-ijms-21-03895">1</a>], particularly for patients with hereditary breast and/or ovarian cancer syndrome (HBOC) but also for sporadic cases [<a href="#B2-ijms-21-03895" class="usa-link" aria-describedby="B2-ijms-21-03895">2</a>,<a href="#B3-ijms-21-03895" class="usa-link" aria-describedby="B3-ijms-21-03895">3</a>,<a href="#B4-ijms-21-03895" class="usa-link" aria-describedby="B4-ijms-21-03895">4</a>]. Over the past decade, the poly (ADP-ribose) polymerase (PARP) family of proteins has been established as an important therapeutic target [<a href="#B5-ijms-21-03895" class="usa-link" aria-describedby="B5-ijms-21-03895">5</a>,<a href="#B6-ijms-21-03895" class="usa-link" aria-describedby="B6-ijms-21-03895">6</a>,<a href="#B7-ijms-21-03895" class="usa-link" aria-describedby="B7-ijms-21-03895">7</a>,<a href="#B8-ijms-21-03895" class="usa-link" aria-describedby="B8-ijms-21-03895">8</a>]. PARPs are involved in DNA repair of single-strand DNA breaks and inhibition of PARP function is based on the concept of synthetic lethality in cancers with simultaneous HR deficiency [<a href="#B9-ijms-21-03895" class="usa-link" aria-describedby="B9-ijms-21-03895">9</a>]. Despite the utility of platinum sensitivity and <em>BRCA1/2</em> variants as predictors of treatment response, there is an urgent need for greater resolution in the predictive capacity of individual <em>BRCA1/2</em> variants to understand the determinants of response related to the degree of HR deficiency. An additional caveat in understanding the clinical significance of detected variants is the enormous diversity of variants that can exist in the general population. To aid this process, the American College of Medical Genetics and Genomics (ACMG) has provided a set of guidelines that enable the classification of variants [<a href="#B10-ijms-21-03895" class="usa-link" aria-describedby="B10-ijms-21-03895">10</a>]. Expanding upon this framework, Molecular Health (MH) developed MH BRCA, a technology that supports the clinical interpretation of <em>BRCA1/2</em> variants by combining the rules laid out in the ACMG guidelines with a proprietary database of expert curated variant annotations. Importantly, MH BRCA also integrates variant population-frequency (PF) data from the Japanese genomic cohort of the Tohoku Medical Megabank Organization (ToMMo) [<a href="#B11-ijms-21-03895" class="usa-link" aria-describedby="B11-ijms-21-03895">11</a>].</p>
<p>In this study, we focused retrospectively on 346 patients (334 with breast and/or ovarian cancer and 12 with prostate cancer) sequenced at the Yamanashi Central Hospital (YCH) with the purpose to compare our <em>BRCA1/2</em> variant interpretation provided by the current clinical workflow with those provided through reanalysis with the MH BRCA technology and to evaluate the predicted response to PARP inhibition with the treatment decision support service MH Guide. The study design is schematically depicted in <a href="#ijms-21-03895-f001" class="usa-link">Figure 1</a>.</p>
<figure class="fig xbox font-sm" id="ijms-21-03895-f001"><h3 class="obj_head">Figure 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7312854_ijms-21-03895-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1025/7312854/3b5e678fc222/ijms-21-03895-g001.jpg" loading="lazy" height="344" width="761" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-21-03895-f001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Study design for the validation of MH BRCA. <em>BRCA1/2</em> variants from Japanese HBOC studies of Arai et al. [<a href="#B12-ijms-21-03895" class="usa-link" aria-describedby="B12-ijms-21-03895">12</a>], Hirotsu et al. [<a href="#B13-ijms-21-03895" class="usa-link" aria-describedby="B13-ijms-21-03895">13</a>], and Nakagomi et al. [<a href="#B14-ijms-21-03895" class="usa-link" aria-describedby="B14-ijms-21-03895">14</a>] were compared to ACMG-guided classifications in MH BRCA with or without the Japanese genomic cohort data of ToMMo. The study of Momozawa et al. [<a href="#B15-ijms-21-03895" class="usa-link" aria-describedby="B15-ijms-21-03895">15</a>] was compared to a consolidated interpretation based on the database consensus classification and the ACMG-guided calculation provided by MH BRCA. Further, datasets of ClinVar submitters ENIGMA, ARUP, and the German Cancer Consortium were used to evaluate the ACMG classification of MH BRCA. Finally, we compared our clinically assessed <em>BRCA1/2</em> classifications from HBOC-related cancer patients sequenced at the Yamanashi Central Hospital. Comparative analysis in each dataset determined the concordance-rate and the reason of discordance. The datasets of our patient cohort and the examined Japanese HBOC studies were analyzed for predicted treatment response to PARP inhibition in MH Guide. Results were correlated to the corresponding BRCA1/2 variant classification by MH BRCA.</p></figcaption></figure></section><section id="sec2-ijms-21-03895"><h2 class="pmc_sec_title">2. Results</h2>
<section id="sec2dot1-ijms-21-03895"><h3 class="pmc_sec_title">2.1. Pre-Evaluation of MH BRCA</h3>
<p>We first tested the diagnostic support of the tool by comparing <em>BRCA1/2</em> classifications from a case/control study on 7051 Japanese HBOC patients and 11,241 controls [<a href="#B13-ijms-21-03895" class="usa-link" aria-describedby="B13-ijms-21-03895">13</a>]. Momozawa et al. classified variants of 11 breast cancer genes based on the ruleset of the ACMG guideline [<a href="#B10-ijms-21-03895" class="usa-link" aria-describedby="B10-ijms-21-03895">10</a>]. This study used the 3-Tier system for the classification of pathogenic, benign, and variants of unknown significance (VUS). A total of 838 unique <em>BRCA1/2</em> variants were pooled from the female and male dataset. As MH BRCA provides classifications from reputable variant annotation databases (DB), we examined the public accessible knowledge in this dataset. The DB consensus classification, summarizing variant annotations from the expert consortia ENIGMA and BIC, both from BRCA exchange [<a href="#B16-ijms-21-03895" class="usa-link" aria-describedby="B16-ijms-21-03895">16</a>], ClinVar [<a href="#B17-ijms-21-03895" class="usa-link" aria-describedby="B17-ijms-21-03895">17</a>], and the ARUP Laboratories of the University of Utah (<a href="http://arup.utah.edu/database/BRCA/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://arup.utah.edu/database/BRCA/</a>), demonstrated that 40.5% of variants were not documented in the public domain (<a href="#ijms-21-03895-f002" class="usa-link">Figure 2</a>A and <a href="#app1-ijms-21-03895" class="usa-link">Table S2</a>). In contrast, ACMG-guided classification was possible on the full dataset and revealed in the cluster analysis of the pathogenic subset a strong concordance of 96.8% with Momozawa et al. (<a href="#ijms-21-03895-f002" class="usa-link">Figure 2</a>B). Analysis of the benign subset showed an unsatisfying low performance in the ACMG-guided interpretation, whereas combined with the DB consensus classification, it increased the accuracy in prediction of benignity to 95.3% concordance, underlining the benefit of the consolidated variant interpretation (<a href="#ijms-21-03895-f002" class="usa-link">Figure 2</a>C). In the largest subset of undetermined VUS, we found in 41.9% of cases reclassification by MH BRCA (<a href="#ijms-21-03895-f002" class="usa-link">Figure 2</a>D). In summary, the consolidated variant interpretation demonstrated strong concordance with clinical assessed <em>BRCA1/2</em> classifications and indicated the potential for enhanced VUS reclassification.</p>
<figure class="fig xbox font-sm" id="ijms-21-03895-f002"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7312854_ijms-21-03895-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1025/7312854/b03981604377/ijms-21-03895-g002.jpg" loading="lazy" height="505" width="755" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-21-03895-f002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Impact of Japanese genomic cohort data evaluated in datasets of Japanese HBOC studies. (<strong>A</strong>) ACMG-guided classifications of 838 unique <em>BRCA1/2</em> variants collected from the study of Momozawa et al. [<a href="#B15-ijms-21-03895" class="usa-link" aria-describedby="B15-ijms-21-03895">15</a>] were compared to MH BRCA on the level of database consensus, ACMG-guided calculation and consolidated interpretation. Classification based on a 3 or 5-Tier system is shown in percentage. (<strong>B</strong>) Cluster analysis of 154 pathogenic classified variants. (<strong>C</strong>) Cluster analysis of 150 benign classified variants. (<strong>D</strong>) Cluster analysis of 534 VUS classified variants. (<strong>E</strong>) Classifications of 202 <em>BRCA1/2</em> variants were pooled together from three Japanese HBOC studies [<a href="#B12-ijms-21-03895" class="usa-link" aria-describedby="B12-ijms-21-03895">12</a>,<a href="#B13-ijms-21-03895" class="usa-link" aria-describedby="B13-ijms-21-03895">13</a>,<a href="#B14-ijms-21-03895" class="usa-link" aria-describedby="B14-ijms-21-03895">14</a>] and were compared to MH BRCA with or without the Japanese genomic cohort data of ToMMo. Classification based on the 5-Tier system is shown in percentage. (<strong>F</strong>) Cluster analysis of pooled pathogenic and likely pathogenic classified variants (<em>n</em> = 116), (<strong>G</strong>) cluster analysis of pooled benign and likely benign classified variants (<em>n</em> = 38), (<strong>H</strong>) cluster analysis of pooled VUS classified variants (<em>n</em> = 48). (<strong>I</strong>) Merged classifications of 1040 <em>BRCA1/2</em> variants from four Japanese HBOC studies. (<strong>J</strong>) Blotted classification-matrix illustrates concordance (green) and discordance affecting clinical decisions (red). (<strong>K</strong>) Percentage of concordance in each cluster. Abbreviations: P = pathogenic; LP = likely pathogenic; VUS = variant of unknown significance; LB = likely benign; B = benign.</p></figcaption></figure></section><section id="sec2dot2-ijms-21-03895"><h3 class="pmc_sec_title">2.2. Impact of Japanese Genomic Cohort Data</h3>
<p>We next investigated the contribution of Japanese-specific PF data from ToMMo for the determination of benign variants in Japan. As Momozawa et al. used the ToMMo data for assessment of benign polymorphisms, we selected three additional Japanese HBOC studies. To this end, we used the study of Nakagomi et al. [<a href="#B18-ijms-21-03895" class="usa-link" aria-describedby="B18-ijms-21-03895">18</a>] with clinical assessed interpretations of <em>BRCA1/2</em> variants and studies of Hirotsu et al. [<a href="#B15-ijms-21-03895" class="usa-link" aria-describedby="B15-ijms-21-03895">15</a>] and Arai et al. [<a href="#B14-ijms-21-03895" class="usa-link" aria-describedby="B14-ijms-21-03895">14</a>] with classifications from FALCO Biosystems using the license of Myriad Genetics (Salt Lake City, UT, USA). Benign classifications were either based on the clinical occurrence-rate or reported test results, whereas Hirotsu et al. used in addition the Japanese-specific HGVD database of Kyoto University, Japan [<a href="#B12-ijms-21-03895" class="usa-link" aria-describedby="B12-ijms-21-03895">12</a>]. <em>BRCA1/2</em> variants reported with an allele frequency &gt;1% in an outbred population cohort are considered as benign in accordance with the ENIGMA classification criteria. A comparison of each study with MH BRCA in the absence or presence of ToMMo data with PF &gt; 1% revealed an improvement exclusively in the benign category (<a href="#ijms-21-03895-f002" class="usa-link">Figure 2</a>E and <a href="#app1-ijms-21-03895" class="usa-link">Figure S1</a>). Cluster analysis in the pooled dataset was associated with consistent pathogenic or likely pathogenic interpretation (<a href="#ijms-21-03895-f002" class="usa-link">Figure 2</a>F). Analysis of the pooled benign/likely benign subset demonstrated that adding Japanese-specific PF data to MH BRCA increased the benign classifications by 10.5%, highlighting the improvement due to integrated ToMMo genomic cohort data (<a href="#ijms-21-03895-f002" class="usa-link">Figure 2</a>G). Reclassification of VUS was found in 22 out of 48 variants (<a href="#ijms-21-03895-f002" class="usa-link">Figure 2</a>H and <a href="#app1-ijms-21-03895" class="usa-link">Table S2</a>).</p>
<p>To assess the importance of Japanese-specific PF data, we compared ToMMo with the 1000 Genomes Project data (1000G) [<a href="#B19-ijms-21-03895" class="usa-link" aria-describedby="B19-ijms-21-03895">19</a>], the Exome Aggregation Consortium (<em>ExAC</em>) [<a href="#B20-ijms-21-03895" class="usa-link" aria-describedby="B20-ijms-21-03895">20</a>], and the Genome Aggregation Database (GnomAD) [<a href="#B21-ijms-21-03895" class="usa-link" aria-describedby="B21-ijms-21-03895">21</a>]. The Japanese cohort-size of ToMMo includes 3554 individuals and is 30-fold higher than from the 1000G data (120 of 4888 individuals), whereas ExAC and GnomAD data used a general East-Asian population cohort. Comparison based on the pooled benign subset from the examined four Japanese HBOC studies showed that assessment of benign variants was in 33 out of 176 variants (19%) based on reliable data with PF &gt; 1% (<a href="#app1-ijms-21-03895" class="usa-link">Figure S2</a>). Although ToMMo and 1000G had similar performance in the Japanese-cohort, a difference in the magnitude of PF-values was evident, whereas global as well as the general East-Asian population cohorts of ExAC and GnomAD were of low validity in the Japanese population (<a href="#app1-ijms-21-03895" class="usa-link">Table S3</a>).</p></section><section id="sec2dot3-ijms-21-03895"><h3 class="pmc_sec_title">2.3. Performance Indication of Consolidated BRCA1/2 Variant Interpretation</h3>
<p>The overall measurement of MH BRCA performance in the test datasets was based on pooled <em>BRCA1/2</em> classifications (<em>n</em> = 1040) from four Japanese HBOC studies. Results showed 74.3% concordance with the interpretations of the examined studies and demonstrated particularly strong concordance within the pathogenic (98.1%) and benign (91%) subset (<a href="#ijms-21-03895-f002" class="usa-link">Figure 2</a>I–K). Analysis of discordant interpretations showed that in the dataset of Momozawa et al. the missense variants <em>BRCA1</em> p.K1095E and <em>BRCA2</em> p.R174C (rs41293469), the small deletion <em>BRCA2</em> p.N1023_I1024del (rs730881605) and the last exon frameshift <em>BRCA2</em> p.N3407fs were reclassified in MH BRCA from pathogenic to VUS and the variant <em>BRCA2</em> p.R3052Q (rs80359171) to likely benign (<a href="#ijms-21-03895-f002" class="usa-link">Figure 2</a>J and <a href="#app1-ijms-21-03895" class="usa-link">Table S2</a>). The latter variant was also classified as likely benign in the ARUP database relying on a genetic assessment study [<a href="#B22-ijms-21-03895" class="usa-link" aria-describedby="B22-ijms-21-03895">22</a>] and supported by curated evidence showing no damaging effect in the complementation assay, HR capacity, and cisplatin sensitivity [<a href="#B23-ijms-21-03895" class="usa-link" aria-describedby="B23-ijms-21-03895">23</a>]. Most contribution in discordance was due to VUS reclassification in 246 out of 582 variants with information gain for pathogenic (<em>n</em> = 2), likely pathogenic (<em>n</em> = 15), likely benign (<em>n</em> = 203), and benign (<em>n</em> = 26). Taken together, MH BRCA demonstrated its support in evidence-based <em>BRCA1/2</em> variant interpretation.</p></section><section id="sec2dot4-ijms-21-03895"><h3 class="pmc_sec_title">2.4. Comparison to ClinVar Submitter Content for BRCA1/2 Variant Classification</h3>
<p>To evaluate the validity of the ACMG criteria interpretation made by the automated calculation in MH BRCA, we tested additional datasets of ClinVar submitter content of ENIGMA, ARUP, and the German Cancer Consortium (<a href="#ijms-21-03895-f003" class="usa-link">Figure 3</a>A–C and <a href="#app1-ijms-21-03895" class="usa-link">Table S2</a>). Overall, in the three datasets, a concordance-rate of 99.98% was detected in the interpretation of pathogenicity with one discordant variant <em>BRCA1</em> p.L1365V (rs1567788936) in the German Cancer Consortium dataset (<a href="#ijms-21-03895-f003" class="usa-link">Figure 3</a>C,D). A comparison of discordant variant classifications revealed an improvement for VUS reclassification in 32 out of 43 variants in the ARUP dataset (<a href="#ijms-21-03895-f003" class="usa-link">Figure 3</a>B). In the ENIGMA dataset also 9 variants were reclassified with clinical impact by the tool (<a href="#ijms-21-03895-f003" class="usa-link">Figure 3</a>A). Detailed analysis of the reasons for discordance demonstrated that variant annotations impacting the ACMG criteria PS3 and BS3 (well-established functional evidence) are important indicators for reclassification (<a href="#app1-ijms-21-03895" class="usa-link">Table S4</a>). However, the interpretation of likely benign variants varied massively, especially in the dataset of ENIGMA, for which possible reasons are discussed. In sum, the ACMG calculation made by MH BRCA confirmed its validity in the interpretation of pathogenicity.</p>
<figure class="fig xbox font-sm" id="ijms-21-03895-f003"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7312854_ijms-21-03895-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1025/7312854/7082b5d44ab6/ijms-21-03895-g003.jpg" loading="lazy" height="374" width="738" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-21-03895-f003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Comparison to ClinVar submitter content for <em>BRCA1/2</em> variant classification. Blotted classification-matrix illustrates concordance (green) and discordance of clinical significance (red). (<strong>A</strong>) ClinVar submitter content from ENIGMA included classifications of 7208 <em>BRCA1/2</em> variants. (<strong>B</strong>) ClinVar submitter content from the ARUP laboratories included classifications of 342 <em>BRCA1/2</em> variants. (<strong>C</strong>) ClinVar submitter content from the German Cancer Consortium included classifications of 90 <em>BRCA1/2</em> variants. (<strong>D</strong>) Concordance-rate in each dataset of examined ClinVar submitters is shown for the pathogenic/likely pathogenic and the benign/likely benign subset.</p></figcaption></figure><section id="sec2dot4dot1-ijms-21-03895"><h4 class="pmc_sec_title">2.4.1. Clinical Evaluation of MH BRCA</h4>
<p>To determine the clinical significance, we analyzed in MH BRCA retrospectively in 149 <em>BRCA1/2</em> variant positive cases from a total of 346 patients with breast, ovarian, or prostate cancer, which were sequenced at the YCH to test for an indication of HBOC or HPC syndrome, respectively. This included 142 breast and/or ovarian cancer and 7 prostate cancer cases with altogether 84 unique <em>BRCA1/2</em> variants. Clinical assessment at the YCH of <em>BRCA1/2</em> variant positive cases revealed deleterious <em>BRCA1/2</em> variants in 26 patients (17%) and variants classified as VUS in 34 patients (23%). A comparison of our results with classifications provided by MH BRCA demonstrated a complete overlap in the interpretation of pathogenicity and benignity (<a href="#ijms-21-03895-f004" class="usa-link">Figure 4</a>A–C). The discrepancy in the interpretation of two likely benign variants were compensated by the information-gain for VUS reclassification in 17 out of 26 variants. Analysis of the clinical decision impact highlighted that one discordant case of clinical relevance would affect patient treatment decisions. Case analysis of the likely pathogenic reclassified VUS variant <em>BRCA1</em> p.V1653L (rs80357261) by MH BRCA revealed in our cohort three breast and/or ovarian cancer patients with otherwise no additional pathogenic event in the germline samples, which might be indicative for the disease-causing event (<a href="#ijms-21-03895-t001" class="usa-link">Table 1</a>). Further analysis of variants reclassifying a VUS to likely benign were associated with 22 out of 34 patients (64.7%) with previously undetermined <em>BRCA1/2</em> variants for HBOC/HPC syndrome (<a href="#app1-ijms-21-03895" class="usa-link">Table S5</a>). Conclusively, MH BRCA indicated its clinical relevance due to improved reclassification of VUS.</p>
<figure class="fig xbox font-sm" id="ijms-21-03895-f004"><h5 class="obj_head">Figure 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7312854_ijms-21-03895-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1025/7312854/5237b28cd093/ijms-21-03895-g004.jpg" loading="lazy" height="378" width="745" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-21-03895-f004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Clinical evaluation of MH BRCA. (<strong>A</strong>) Interpretations of 84 <em>BRCA1/2</em> variants clinically assessed at the Yamanashi Central Hospital (YCH) were compared with the results of MH BRCA classifications. 5-Tier system classification is shown in percentage. (<strong>B</strong>) Blotted classification-matrix illustrates concordance (green) and discordance of clinical significance (red). (<strong>C</strong>) Percentage of concordance in each cluster. (<strong>D</strong>) Predicted response to PARP inhibition in the MH Guide of 84 <em>BRCA1/2</em> variants is based on the functional impact of neutral, hypermorphic, or hypomorphic variants in homologous recombination activity and pathomechanism. (<strong>E</strong>) Cluster analysis of MH BRCA classified variants with a predicted response to PARP inhibition in MH Guide within the sub-categories. Abbreviations: P = pathogenic; LP = likely pathogenic; VUS = variant of unknown significance; LB = likely benign; B = benign.</p></figcaption></figure><section class="tw xbox font-sm" id="ijms-21-03895-t001"><h5 class="obj_head">Table 1.</h5>
<div class="caption p"><p>Case analysis of clinically relevant discordant <em>BRCA1/2</em> classification in MH BRCA. The <em>BRCA1</em> variant p.V1653L (rs80357261) was reclassified as likely pathogenic in MH BRCA and found in blood samples of 3 patients without any additional pathogenic germline <em>BRCA1/2</em> variant, which might be indicative for predisposition to HBOC syndrome.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Case-ID</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Gene</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HGVS g.</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HGVS c.</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">HGVS p.</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SNP-ID Number</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">YCH</th>
<th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">MH BRCA</th>
</tr></thead>
<tbody>
<tr>
<td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">BRCA006</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41222974C &gt; A</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4957G &gt; T</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V1653L</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs80357261</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LP</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32914623G &gt; T</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6131G &gt; T</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G2044V</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs56191579</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td>
</tr>
<tr>
<td rowspan="4" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">BRCA008</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41222974C &gt; A</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4957G &gt; T</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V1653L</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs80357261</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LP</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32914623G &gt; T</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6131G &gt; T</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G2044V</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs56191579</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41243841T &gt; C</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3707A &gt; G</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N1236S</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs863224760</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>BRCA2</em>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32910842A &gt; G</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2350A &gt; G</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">M784V</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs11571653</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">BRCA052</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<em>BRCA1</em>
</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41222974C &gt; A</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4957G &gt; T</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">V1653L</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">rs80357261</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">VUS</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">LP</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/ijms-21-03895-t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="sec2dot4dot2-ijms-21-03895"><h4 class="pmc_sec_title">2.4.2. Correlation of Predicted Efficacy Association to PARP Inhibition by MH Guide</h4>
<p>Finally, we examined to which degree MH BRCA classifications are representative for prediction to HR deficiency and response to PARP inhibition. To this end, we used the treatment decision support software MH Guide, providing treatment biomarkers and functional variant annotations. First, we assessed the outcome of our pre-evaluation test dataset from the examined four Japanese HBOC studies (<a href="#app1-ijms-21-03895" class="usa-link">Figure S3A–D</a>). Treatment efficacy association for a response to PARP inhibition was remarkable covered in 95.4% of classified pathogenic variants by MH BRCA. In contrast, 87.6% of classified benign variants correlated with the prediction of resistance to PARP inhibition due to functional evidence for a neutral variant (<a href="#app1-ijms-21-03895" class="usa-link">Figure S3E,F and Table S2</a>). Although, VUS and likely benign classified variants by MH BRCA were largely not covered in MH Guide due to lack of functional evidence, yet 22 out of 357 VUS (6.2%) and 10 out of 296 likely benign (3.4%) variants were predicted to resistance to PARP inhibition (<a href="#app1-ijms-21-03895" class="usa-link">Figure S3F and Table S2</a>). Interestingly, predicted low response to PARP inhibition due to hypomorphic variants conferring partially impaired moderate HR deficiency were reported in 11 variants classified as pathogenic, in 2 as VUS, 2 as likely benign, and 1 as benign.</p>
<p>Correlation of our clinical dataset of 149 <em>BRCA1/2</em> variant positive patient cases demonstrated complete coverage in the MH Guide of pathogenic and likely pathogenic variants with predicted response to PARP inhibition and benign variants with resistance to treatment (<a href="#ijms-21-03895-f004" class="usa-link">Figure 4</a>D,E). In our dataset one variant, <em>BRCA2</em> p.I2675V (rs397507954), classified as likely pathogenic was predicted to be associated with low-efficacy to PARP inhibition [<a href="#B15-ijms-21-03895" class="usa-link" aria-describedby="B15-ijms-21-03895">15</a>]. Moreover, 1 out of 11 VUS and 1 out of 11 likely benign classified variants were predicted to confer resistance to treatment. Collectively, contextualizing the results of the consolidated <em>BRCA1/2</em> variant interpretation by MH BRCA with functional variant annotations of treatment biomarkers in the MH Guide highlighted an additional degree of information-gain for treatment response profiles.</p></section></section></section><section id="sec3-ijms-21-03895"><h2 class="pmc_sec_title">3. Discussion</h2>
<p>In this study, we sought to characterize the feasibility of using MH BRCA and MH Guide to support the clinical interpretation of NGS panel data from potentially HBOC-related cancer patients at the Yamanashi Central Hospital. Comparison to the test datasets of four examined HBOC studies and ClinVar submitter content of ENIGMA, ARUP, and German Cancer Consortium showed strong concordance in the assessment of pathogenicity. However, discordance in ACMG-guided interpretation of benign/likely benign classified variants in the ENIGMA dataset was evident. A potential reason is the ACMG criteria for the assessment of a synonymous (silent) variant for which splicing prediction algorithms predict no impact to the splice consensus sequence nor the creation of a new splice site and the nucleotide is not highly conserved (BP7). This criterion was not yet evaluated by MH BRCA during manuscript preparation. ENIGMA assessed the predicted splicing effects of synonymous variants by in silico calculation using the PRIORS tool of the University of UTAH. In addition, ENIGMA consortium decisions include also multifactorial likelihood models, which take into consideration family segregation data and trans/co-occurrence data, criteria which are not automatically assessed by MH BRCA due to case sensitive nature of such information. Discordance in benign classification to the study Momozawa et al. were mostly related to the ACMG criteria BS1, which incorporates information of allele frequency greater as expected for the disorder, and is automatically calculated by MH BRCA with a threshold of PF &gt; 0.01% for HBOC-related genes in accordance to Kobayashi et al. [<a href="#B24-ijms-21-03895" class="usa-link" aria-describedby="B24-ijms-21-03895">24</a>].</p>
<p>In our clinical assessed <em>BRCA1/2</em> variant positive cohort the improvement of variant interpretation with MH BRCA was associated with detection of <em>BRCA1</em> p.V1653L (rs80357261), which showed a deleterious effect in cell viability assays [<a href="#B25-ijms-21-03895" class="usa-link" aria-describedby="B25-ijms-21-03895">25</a>], as a potentially pathogenic variant in three patients. This study of Findlay et al. assessed 3893 SNPs of <em>BRCA1</em> based on the saturation genomic editing method using CRISPR/Cas mediated high-throughput transformation of haploid HAP1 cells and measured the outcome in cell survival dependent on homologous recombination proficiency. Although the artificial nature of this high-throughput assay may be considered with caution (<a href="https://sge.gs.washington.edu/BRCA1/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://sge.gs.washington.edu/BRCA1/</a>), a study investigating the impact of such proactive high-throughput functional assay indicated the usefulness for the reclassification of clinically observed VUS [<a href="#B26-ijms-21-03895" class="usa-link" aria-describedby="B26-ijms-21-03895">26</a>]. Moreover, another substitution at this residue in the BRCT domain, the <em>BRCA1</em> p.V1653M (rs80357261), showed a loss of transcriptional activity, slightly compromised protein binding abilities, and increased protease susceptibility, indicating a defect in protein folding [<a href="#B27-ijms-21-03895" class="usa-link" aria-describedby="B27-ijms-21-03895">27</a>]. For this reason, the percentage of patient cases with high HBOC risk increased from 26 to 29 patients (19% of cases), whereas none of the potentially HPC cases carried a deleterious <em>BRCA1/2</em> variant. The same incidence of HBOC syndrome was reported with 19.7% by the HBOC registration study of Arai et al. [<a href="#B14-ijms-21-03895" class="usa-link" aria-describedby="B14-ijms-21-03895">14</a>] but lower than found by Nakamura et al. with 30.7% in HBOC-associated breast cancer patients [<a href="#B28-ijms-21-03895" class="usa-link" aria-describedby="B28-ijms-21-03895">28</a>]. Refinement of patients with VUS into likely benign variants based on ACMG criteria strikingly reduced the uncertainty of germline-derived cancer-predisposing syndromes in 22 out of 34 patients. Recently, the corresponding variants were likewise predicted to be functionally neutral by a sequence-based computational model [<a href="#B29-ijms-21-03895" class="usa-link" aria-describedby="B29-ijms-21-03895">29</a>].</p>
<p>The potential degree of a predicted PARP inhibitor efficacy can be assessed in MH Guide based on experimental evidence for the impact on HR functionality due to hyper- or hypomorphic variants. In our patient cohort, the variant <em>BRCA2</em> p.I2675V (rs397507954) was reported to cause splicing defect with in-frame deletion resulting in a truncated protein of unknown impact on the vulnerability of HR activity [<a href="#B15-ijms-21-03895" class="usa-link" aria-describedby="B15-ijms-21-03895">15</a>]. In the validation dataset of the Japanese HBOC studies, an additional 11 out of 282 pathogenic classified variants (3.9%) by MH BRCA were predicted with low efficacy to PARP inhibition due to evidence for incomplete splicing defect or partial HR proficiency. However, conflicting experimental evidence or interpretation based solely on certain functional aspects, like compromised protein binding ability or reduced transactivation activity, complicate treatment decisions. Therefore, the predicted low efficacy to treatment considers variants to be monitored for potential inefficacy to PARP inhibition. Interestingly, two variants classified as benign in MH BRCA and Momozawa et al. [<a href="#B13-ijms-21-03895" class="usa-link" aria-describedby="B13-ijms-21-03895">13</a>], <em>BRCA2</em> p.T582P (rs80358457) and <em>BRCA2</em> p.R2108C (rs55794205), were predicted to have low response to PARP inhibition due to hypomorphic nature of the variants. Surprisingly, the variant <em>BRCA2</em> p.T582P (rs80358457) was classified in addition also by others as benign in multifactorial analysis or accordance with ACMG guidelines [<a href="#B30-ijms-21-03895" class="usa-link" aria-describedby="B30-ijms-21-03895">30</a>,<a href="#B31-ijms-21-03895" class="usa-link" aria-describedby="B31-ijms-21-03895">31</a>]. A review of the functional evidence provided by the MH Guide revealed a disturbing interaction with midbody proteins without affecting HR directed DNA repair activity [<a href="#B32-ijms-21-03895" class="usa-link" aria-describedby="B32-ijms-21-03895">32</a>]. However, the significance of the disruption of <em>BRCA2</em> interactions with midbody components remains to be established [<a href="#B33-ijms-21-03895" class="usa-link" aria-describedby="B33-ijms-21-03895">33</a>]. In contrast, a review of the variant <em>BRCA2</em> p.R2108C (rs55794205) elucidated an increased spontaneous intrachromosomal HR-directed DNA repair activity that may cause genomic instability [<a href="#B34-ijms-21-03895" class="usa-link" aria-describedby="B34-ijms-21-03895">34</a>]. It is plausible that variants associated with increased frequency of cytokinetic defects may contribute to pathogenicity, although not directly related to HR deficiency. Despite this discrepancy between classification and potential clinical impact, it must be emphasized that the benefit of the evidence-based approach of MH Guide and MH BRCA relies on the efficient support of clinicians in the interpretation of treatment relevant variant effects regarding the pathomechanism.</p>
<p>Given the challenge to keep track of the current state of published biomarker knowledge, especially in the light of the numerous high-throughput functional studies on <em>BRCA1/2</em> variants [<a href="#B25-ijms-21-03895" class="usa-link" aria-describedby="B25-ijms-21-03895">25</a>,<a href="#B35-ijms-21-03895" class="usa-link" aria-describedby="B35-ijms-21-03895">35</a>], such a curated evidence database based on published functional studies is of important clinical value [<a href="#B36-ijms-21-03895" class="usa-link" aria-describedby="B36-ijms-21-03895">36</a>]. Nevertheless, uncertainty in the variant interpretation of VUS, the discrepancy in the judgment of the pathogenic contribution, and lack of experimental evidence on variant impact or HR functionality remain key challenges for clinical interpretation. MH BRCA and MH Guide provide the first important step for an efficient, standardized, and transparent workflow in <em>BRCA1/2</em> variant interpretation.</p></section><section id="sec4-ijms-21-03895"><h2 class="pmc_sec_title">4. Material and Methods</h2>
<section id="sec4dot1-ijms-21-03895"><h3 class="pmc_sec_title">4.1. Patients and Methods</h3>
<p>Peripheral blood samples were obtained from a total of 346 breast, ovarian and prostate cancer patients who attended Yamanashi Central Hospital (Yamanashi, Japan) between 2013 and 2018. Our cohort consisted of 334 breast and/or ovarian cancer patients with a high risk for HBOC. This cohort consisted of 239 patients with breast cancer, 15 with breast and ovarian cancer, and 80 with ovarian cancer. In addition, our study included 12 sporadic prostate cancer patients, which were assessed for potential <em>BRCA1/2</em> related hereditary prostate cancer (HPC) risk. Sample preparation is described elsewhere [<a href="#B15-ijms-21-03895" class="usa-link" aria-describedby="B15-ijms-21-03895">15</a>]. Informed consent was obtained from all subjects, and this study was approved by the institutional review board at Yamanashi Central Hospital on Jan 8th, 2012.</p></section><section id="sec4dot2-ijms-21-03895"><h3 class="pmc_sec_title">4.2. Targeted Next-Generation Sequencing (NGS)</h3>
<p>For targeted NGS analysis, the Ion AmpliSeq<sup>TM</sup>
<em>BRCA1</em> and <em>BRCA2</em> Panel (Thermo Fisher Scientific, Waltham, MA, USA) containing 167 primer pairs in three pools or Oncomine <em>BRCA1/2</em> Panel (Thermo Fisher Scientific, Waltham, MA, USA) containing 275 primer pairs in two pools were used [<a href="#B37-ijms-21-03895" class="usa-link" aria-describedby="B37-ijms-21-03895">37</a>]. A detailed protocol of the procedure and analysis of sequenced data is described in our previous reports [<a href="#B15-ijms-21-03895" class="usa-link" aria-describedby="B15-ijms-21-03895">15</a>]. Massively parallel sequencing was carried out on a Personal Genome Machine (PGM) sequencer (Ion Torrent<sup>TM</sup>) using the Ion PGM Sequencing 200 Kit version 2 according to the manufacturer’s instructions. Sequence data were visually confirmed with the Integrative Genomics Viewer (IGV) and any sequence, alignment, or variant call error artifacts were discarded.</p></section><section id="sec4dot3-ijms-21-03895"><h3 class="pmc_sec_title">4.3. Data Analysis for Clinical Assessment of BRCA1/2 Interpretation</h3>
<p>Classification of the deleterious variant was applied for frameshift, nonsense, and splice-site mutations that lead to premature truncation of the protein. Most of the cases were analyzed for their large deletion by the multiplex ligation-dependent probe amplification (MLPA) method which was carried out by FALCO Biosystems (Kyoto, Japan). Missense variants with minor allele frequency (MAF) &lt;0.01 were selected as rare variants according to 1000 Genomes Project data [<a href="#B19-ijms-21-03895" class="usa-link" aria-describedby="B19-ijms-21-03895">19</a>], the 5000 Exome project (<a href="http://evs.gs.washington.edu/EVS/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://evs.gs.washington.edu/EVS/</a>), and the Human Genetic Variation Database (HGVD) (<a href="http://www.genome.med.kyoto-u.ac.jp/SnpDB" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www.genome.med.kyoto-u.ac.jp/SnpDB</a>). Variants were annotated using the BIC database, the representative ClinVar database [<a href="#B17-ijms-21-03895" class="usa-link" aria-describedby="B17-ijms-21-03895">17</a>] and computational annotation systems (SIFT and PolyPhen2). Clinical features associated with HBOC have been determined based on personal and family history, histology of ovarian cancer (serous or non-serous) and breast cancer (triple-negative breast cancer [TNBC] or non-TNBC), age of developing breast cancer (≤45 years or older), and whether bilateral or unilateral breast cancer.</p></section><section id="sec4dot4-ijms-21-03895"><h3 class="pmc_sec_title">4.4. Study Design for Validation of MH BRCA</h3>
<p>Comparison of <em>BRCA1/2</em> variant interpretations from our clinical assessed patient cohort and four Japanese HBOC studies, as well as the ClinVar submitter content from ENIGMA, ARUP laboratories, and the German Cancer Consortium was performed with MH BRCA (<a href="https://www.molecularhealth.com/eu/home/mh-brca/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.molecularhealth.com/eu/home/mh-brca/</a>). ClinVar content was extracted by ClinVar Miner (<a href="https://clinvarminer.genetics.utah.edu/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://clinvarminer.genetics.utah.edu/</a>) version 2019-12. Results of MH BRCA classification from our patient cohort and the examined Japanese HBOC studies were tested for associated PARP inhibitor efficacy, using the treatment decision support service MH Guide (<a href="https://www.molecularhealth.com/eu/home/mh-guide/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.molecularhealth.com/eu/home/mh-guide/</a>).</p></section><section id="sec4dot5-ijms-21-03895"><h3 class="pmc_sec_title">4.5. BRCA1/2 Interpretation by MH BRCA</h3>
<p>MH BRCA technology combines ACMG guided interpretation with a proprietary database of expert-curated variant annotations and provides in addition to it a consensus classification of reputable variant annotation databases (ENIGMA, BIC, ClinVar, ARUP). Automated variant assessment on ACMG criteria is performed in accordance with the ruleset of the ACMG guideline [<a href="#B10-ijms-21-03895" class="usa-link" aria-describedby="B10-ijms-21-03895">10</a>] by calculation and interpretation of 17 out of 28 ACMG codes (<a href="#app1-ijms-21-03895" class="usa-link">Table S1</a>). To analyze <em>BRCA1/2</em> variants with the tool, a Variant Call Format (VCF) was generated, containing genomic coordinates of each variant based on the Reference Genome hg19/GRCh37 according to the nomenclature of the Human Genome Variation Society (HGVS). Translation of RefSeq transcripts of <em>BRCA1</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_007294.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_007294.3</a>) and <em>BRCA2</em> (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000059.3" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NM_000059.3</a>) into genomic HGVS coordinates were performed with ENSEMBL’s Variant Effect Predictor tool (<a href="http://grch37.ensembl.org/Tools/VEP" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://grch37.ensembl.org/Tools/VEP</a>). Classification accuracy was determined by cluster analysis of concordant and discordant interpretations in each classification subset (3- or 5-Tier system) and the concordance-rate was calculated. Discordant variant interpretations were depicted in a classification matrix. The clinical decision impact of discrepant classifications was defined by discordance in pathogenic and likely pathogenic variant interpretations.</p></section><section id="sec4dot6-ijms-21-03895"><h3 class="pmc_sec_title">4.6. BRCA1/2 Interpretation for Predicted Treatment Response to PARP Inhibition</h3>
<p>MH Guide is a treatment decision support service to assist physicians in the clinical interpretation of NGS results coming from cancer patients and their tumors. The Dataome technology (<a href="https://www.molecularhealth.com/de/technologie/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.molecularhealth.com/de/technologie/</a>) provides an integrated analysis of a patient’s clinical and molecular cancer data derived from DNA sequence and searches the list of identified variants against a database of both established and emergent treatment biomarkers. These incorporate functional impact information of variants together with published treatment-related effects from regulatory agency recommendations, clinical trials, case reports, and pre-clinical studies. Following the Association of Molecular Pathology (AMP) guideline recommendations and by matching and contextualizing this knowledge with respect to the current patient condition, MH Guide provides clinicians with a prioritized list of drugs that are potentially effective, potentially ineffective, and/or potentially toxic for the patient. Prediction of the pathogenic effect of <em>BRCA1/2</em> variants and their potential DNA damage repair activity using curated functional evidence of the variant impact on protein, distinguishing hyper- and hypomorphic <em>BRCA1/2</em> variants.</p></section><section id="sec4dot7-ijms-21-03895"><h3 class="pmc_sec_title">4.7. Data Availability Statement</h3>
<p>The authors declare that all relevant data supporting the findings of this study are available within the paper and its <a href="#app1-ijms-21-03895" class="usa-link">supplementary information files</a>.</p></section><section id="sec4dot8-ijms-21-03895"><h3 class="pmc_sec_title">4.8. Code Availability</h3>
<p>The authors declare that the code or algorithm has restrictions to access due to CAP- and CLIA-certified commercial product registered as an IVD medical device in the EU.</p></section></section><section id="app1-ijms-21-03895" class="app"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<p>The following are available online at <a href="https://www.mdpi.com/1422-0067/21/11/3895/s1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.mdpi.com/1422-0067/21/11/3895/s1</a>, Figure S1: Comparison of MH BRCA to Japanese HBOC studies. Classifications of <em>BRCA1/2</em> variants were compared to results in MH BRCA with or without the Japanese genomic cohort data of ToMMo. Data were taken from the studies of (A) Hirotsu et al. [<a href="#B13-ijms-21-03895" class="usa-link" aria-describedby="B13-ijms-21-03895">13</a>] (<em>n</em> = 24), (B) Arai et al. [<a href="#B12-ijms-21-03895" class="usa-link" aria-describedby="B12-ijms-21-03895">12</a>] (<em>n</em> = 137), and (C) Nakagomi et al. [<a href="#B14-ijms-21-03895" class="usa-link" aria-describedby="B14-ijms-21-03895">14</a>] (<em>n</em> = 41), Figure S2: Comparison of Japanese-specific population-frequency data in ToMMo, 1000 Genomes, <em>ExAC</em>, and GnomAD. Benign classifications of 176 <em>BRCA1/2</em> variants were pooled together from four Japanese HBOC studies [<a href="#B12-ijms-21-03895" class="usa-link" aria-describedby="B12-ijms-21-03895">12</a>,<a href="#B13-ijms-21-03895" class="usa-link" aria-describedby="B13-ijms-21-03895">13</a>,<a href="#B14-ijms-21-03895" class="usa-link" aria-describedby="B14-ijms-21-03895">14</a>,<a href="#B15-ijms-21-03895" class="usa-link" aria-describedby="B15-ijms-21-03895">15</a>]. PF data of MH BRCA including the Japanese genomic cohort data of ToMMo were compared with the 1000 Genomes Project data (1000G), the Exome Aggregation Consortium (<em>ExAC</em>), and the Genome Aggregation Database (GnomAD). Abbreviation: PF = population-frequency; JPN = Japan; EAS = East Asia, Figure S3: Correlation of MH BRCA classifications from Japanese HBOC studies with predicted response to PARP inhibition in MH Guide. (A–D) Predicted response to PARP inhibition in MH Guide of 1040 <em>BRCA1/2</em> variants collected from four Japanese HBOC studies [<a href="#B12-ijms-21-03895" class="usa-link" aria-describedby="B12-ijms-21-03895">12</a>,<a href="#B13-ijms-21-03895" class="usa-link" aria-describedby="B13-ijms-21-03895">13</a>,<a href="#B14-ijms-21-03895" class="usa-link" aria-describedby="B14-ijms-21-03895">14</a>,<a href="#B15-ijms-21-03895" class="usa-link" aria-describedby="B15-ijms-21-03895">15</a>] is based on the functional impact of neutral, hypermorphic, or hypomorphic variants in homologous recombination activity. (E,F) Cluster analysis of MH BRCA classified variants with predicted response to PARP inhibition in MH Guide within the sub-categories, Table S1: ACMG criteria used in MH BRCA. This table lists the 28 ACMG criteria examined to establish the variant classification by the ACMG guidelines. MH BRCA automatically evaluate 17 criteria based on the NGS data. The data sources consulted for each ACMG criterion are shown, Table S2: RAW datasets of <em>BRCA1/2</em> variant classifications from four Japanese HBOC studies, ClinVar submitter content and YCH compared to MH BRCA. Classifications from <em>BRCA1/2</em> variants of four published HBOC studies [<a href="#B12-ijms-21-03895" class="usa-link" aria-describedby="B12-ijms-21-03895">12</a>,<a href="#B13-ijms-21-03895" class="usa-link" aria-describedby="B13-ijms-21-03895">13</a>,<a href="#B14-ijms-21-03895" class="usa-link" aria-describedby="B14-ijms-21-03895">14</a>,<a href="#B15-ijms-21-03895" class="usa-link" aria-describedby="B15-ijms-21-03895">15</a>], the ClinVar submitter content of ENIGMA, ARUP or German Cancer Consortium, and the Yamanashi Central Hospital (YCH) are shown in comparison to MH BRCA, Table S3: Comparison of population-frequencies in ToMMo, 1000G, ExAC, or GnomAD. Selected examples of diversity in PF data between the investigated databases. Color code used for visualization: PF &gt; 5% (dark green), PF &gt; 1% (green), PF &gt; 0.1% (light green), and PF &lt; 0.1 % (white). Abbreviations: PF = population-frequency; JPN = Japan; EAS = East Asia, Table S4: Discordance in ClinVar submitter datasets. Discordant classifications of interest from <em>BRCA1/2</em> variants of the ClinVar submitter content of ENIGMA, ARUP or German Cancer Consortium are shown in comparison to MH BRCA. Variants of interest were selected based on reclassification of VUS or clinically relevance of the reclassified variants, Table S5: Case analysis of VUS classified <em>BRCA1/2</em> variants. The patient cases with BRCA1/2 variants found in blood samples were classified as VUS by the YCH interpretation workflow and in part reclassified by MH BRCA.</p>
<section class="sm xbox font-sm" id="ijms-21-03895-s001"><div class="media p"><div class="caption">
<a href="/articles/instance/7312854/bin/ijms-21-03895-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (1.5MB, zip) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Y.H., U.S.-E., H.N., I.S., T.G.S., and D.B.J. contributed to manuscript writing, analysis, and interpretation of data, Y.H., U.S.-E., H.N., I.S., and M.O. contributed to acquisition of data, M.H. and R.N. performed bioinformatic analysis, Y.H., U.S.-E., S.K., S.H., S.B., D.B.J., and M.O. contributed to the conception and design of the work, Y.H., U.S.-E., X.W., M.O., and D.B.J. contributed to the drafting of the work. All authors have read and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This research received no external funding.</p></section><section id="notes3"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>Udo Schmidt-Edelkraut, Markus Hartenfeller, Ram Narang, Theodoros Soldatos, Sajo Kaduthanam, Xiaoyue Wang, Stephan Hettich, Stephan Brock, and David Jackson are employees at Molecular Health GmbH. All other authors declare no conflict of interest.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1-ijms-21-03895">
<span class="label">1.</span><cite>Hoppe M.M., Sundar R., Tan D.S.P., Jeyasekharan A.D. Biomarkers for Homologous Recombination Deficiency in Cancer. J. Natl. Cancer Inst. 2018;110:704–713. doi: 10.1093/jnci/djy085.</cite> [<a href="https://doi.org/10.1093/jnci/djy085" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29788099/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Natl.%20Cancer%20Inst.&amp;title=Biomarkers%20for%20Homologous%20Recombination%20Deficiency%20in%20Cancer&amp;author=M.M.%20Hoppe&amp;author=R.%20Sundar&amp;author=D.S.P.%20Tan&amp;author=A.D.%20Jeyasekharan&amp;volume=110&amp;publication_year=2018&amp;pages=704-713&amp;pmid=29788099&amp;doi=10.1093/jnci/djy085&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2-ijms-21-03895">
<span class="label">2.</span><cite>Alsop K., Fereday S., Meldrum C., deFazio A., Emmanuel C., George J., Dobrovic A., Birrer M.J., Webb P.M., Stewart C., et al.  BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: A report from the Australian Ovarian Cancer Study Group. J. Clin. Oncol. 2012;30:2654–2663. doi: 10.1200/JCO.2011.39.8545.</cite> [<a href="https://doi.org/10.1200/JCO.2011.39.8545" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3413277/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22711857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&amp;title=BRCA%20mutation%20frequency%20and%20patterns%20of%20treatment%20response%20in%20BRCA%20mutation-positive%20women%20with%20ovarian%20cancer:%20A%20report%20from%20the%20Australian%20Ovarian%20Cancer%20Study%20Group&amp;author=K.%20Alsop&amp;author=S.%20Fereday&amp;author=C.%20Meldrum&amp;author=A.%20deFazio&amp;author=C.%20Emmanuel&amp;volume=30&amp;publication_year=2012&amp;pages=2654-2663&amp;pmid=22711857&amp;doi=10.1200/JCO.2011.39.8545&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3-ijms-21-03895">
<span class="label">3.</span><cite>Burgess M., Puhalla S. BRCA 1/2-Mutation Related and Sporadic Breast and Ovarian Cancers: More Alike than Different. Front. Oncol. 2014;4:19. doi: 10.3389/fonc.2014.00019.</cite> [<a href="https://doi.org/10.3389/fonc.2014.00019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3936197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24579064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Oncol.&amp;title=BRCA%201/2-Mutation%20Related%20and%20Sporadic%20Breast%20and%20Ovarian%20Cancers:%20More%20Alike%20than%20Different&amp;author=M.%20Burgess&amp;author=S.%20Puhalla&amp;volume=4&amp;publication_year=2014&amp;pages=19&amp;pmid=24579064&amp;doi=10.3389/fonc.2014.00019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4-ijms-21-03895">
<span class="label">4.</span><cite>Venkitaraman A.R. Linking the cellular functions of BRCA genes to cancer pathogenesis and treatment. Annu. Rev. Pathol. 2009;4:461–487. doi: 10.1146/annurev.pathol.3.121806.151422.</cite> [<a href="https://doi.org/10.1146/annurev.pathol.3.121806.151422" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18954285/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu.%20Rev.%20Pathol.&amp;title=Linking%20the%20cellular%20functions%20of%20BRCA%20genes%20to%20cancer%20pathogenesis%20and%20treatment&amp;author=A.R.%20Venkitaraman&amp;volume=4&amp;publication_year=2009&amp;pages=461-487&amp;pmid=18954285&amp;doi=10.1146/annurev.pathol.3.121806.151422&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5-ijms-21-03895">
<span class="label">5.</span><cite>Drew Y., Ledermann J., Hall G., Rea D., Glasspool R., Highley M., Jayson G., Sludden J., Murray J., Jamieson D., et al.  Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer. Br. J. Cancer. 2016;114:723–730. doi: 10.1038/bjc.2016.41.</cite> [<a href="https://doi.org/10.1038/bjc.2016.41" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4882768/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27002934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Cancer&amp;title=Phase%202%20multicentre%20trial%20investigating%20intermittent%20and%20continuous%20dosing%20schedules%20of%20the%20poly(ADP-ribose)%20polymerase%20inhibitor%20rucaparib%20in%20germline%20BRCA%20mutation%20carriers%20with%20advanced%20ovarian%20and%20breast%20cancer&amp;author=Y.%20Drew&amp;author=J.%20Ledermann&amp;author=G.%20Hall&amp;author=D.%20Rea&amp;author=R.%20Glasspool&amp;volume=114&amp;publication_year=2016&amp;pages=723-730&amp;pmid=27002934&amp;doi=10.1038/bjc.2016.41&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6-ijms-21-03895">
<span class="label">6.</span><cite>Litton J.K., Rugo H.S., Ettl J., Hurvitz S.A., Goncalves A., Lee K.H., Fehrenbacher L., Yerushalmi R., Mina L.A., Martin M., et al.  Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation. N. Engl. J. Med. 2018;379:753–763. doi: 10.1056/NEJMoa1802905.</cite> [<a href="https://doi.org/10.1056/NEJMoa1802905" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10600918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30110579/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Talazoparib%20in%20Patients%20with%20Advanced%20Breast%20Cancer%20and%20a%20Germline%20BRCA%20Mutation&amp;author=J.K.%20Litton&amp;author=H.S.%20Rugo&amp;author=J.%20Ettl&amp;author=S.A.%20Hurvitz&amp;author=A.%20Goncalves&amp;volume=379&amp;publication_year=2018&amp;pages=753-763&amp;pmid=30110579&amp;doi=10.1056/NEJMoa1802905&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7-ijms-21-03895">
<span class="label">7.</span><cite>Moore K., Colombo N., Scambia G., Kim B.G., Oaknin A., Friedlander M., Lisyanskaya A., Floquet A., Leary A., Sonke G.S., et al.  Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. N. Engl. J. Med. 2018;379:2495–2505. doi: 10.1056/NEJMoa1810858.</cite> [<a href="https://doi.org/10.1056/NEJMoa1810858" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30345884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Maintenance%20Olaparib%20in%20Patients%20with%20Newly%20Diagnosed%20Advanced%20Ovarian%20Cancer&amp;author=K.%20Moore&amp;author=N.%20Colombo&amp;author=G.%20Scambia&amp;author=B.G.%20Kim&amp;author=A.%20Oaknin&amp;volume=379&amp;publication_year=2018&amp;pages=2495-2505&amp;pmid=30345884&amp;doi=10.1056/NEJMoa1810858&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8-ijms-21-03895">
<span class="label">8.</span><cite>Robson M., Im S.A., Senkus E., Xu B., Domchek S.M., Masuda N., Delaloge S., Li W., Tung N., Armstrong A., et al.  Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. N. Engl. J. Med. 2017;377:523–533. doi: 10.1056/NEJMoa1706450.</cite> [<a href="https://doi.org/10.1056/NEJMoa1706450" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28578601/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Olaparib%20for%20Metastatic%20Breast%20Cancer%20in%20Patients%20with%20a%20Germline%20BRCA%20Mutation&amp;author=M.%20Robson&amp;author=S.A.%20Im&amp;author=E.%20Senkus&amp;author=B.%20Xu&amp;author=S.M.%20Domchek&amp;volume=377&amp;publication_year=2017&amp;pages=523-533&amp;pmid=28578601&amp;doi=10.1056/NEJMoa1706450&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9-ijms-21-03895">
<span class="label">9.</span><cite>O’Neil N.J., Bailey M.L., Hieter P. Synthetic lethality and cancer. Nat. Rev. Genet. 2017;18:613–623. doi: 10.1038/nrg.2017.47.</cite> [<a href="https://doi.org/10.1038/nrg.2017.47" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28649135/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Rev.%20Genet.&amp;title=Synthetic%20lethality%20and%20cancer&amp;author=N.J.%20O%E2%80%99Neil&amp;author=M.L.%20Bailey&amp;author=P.%20Hieter&amp;volume=18&amp;publication_year=2017&amp;pages=613-623&amp;pmid=28649135&amp;doi=10.1038/nrg.2017.47&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10-ijms-21-03895">
<span class="label">10.</span><cite>Richards S., Aziz N., Bale S., Bick D., Das S., Gastier-Foster J., Grody W.W., Hegde M., Lyon E., Spector E., et al.  Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405–424. doi: 10.1038/gim.2015.30.</cite> [<a href="https://doi.org/10.1038/gim.2015.30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4544753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25741868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=Standards%20and%20guidelines%20for%20the%20interpretation%20of%20sequence%20variants:%20A%20joint%20consensus%20recommendation%20of%20the%20American%20College%20of%20Medical%20Genetics%20and%20Genomics%20and%20the%20Association%20for%20Molecular%20Pathology&amp;author=S.%20Richards&amp;author=N.%20Aziz&amp;author=S.%20Bale&amp;author=D.%20Bick&amp;author=S.%20Das&amp;volume=17&amp;publication_year=2015&amp;pages=405-424&amp;pmid=25741868&amp;doi=10.1038/gim.2015.30&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11-ijms-21-03895">
<span class="label">11.</span><cite>Nagasaki M., Yasuda J., Katsuoka F., Nariai N., Kojima K., Kawai Y., Yamaguchi-Kabata Y., Yokozawa J., Danjoh I., Saito S., et al.  Rare variant discovery by deep whole-genome sequencing of 1,070 Japanese individuals. Nat. Commun. 2015;6:8018. doi: 10.1038/ncomms9018.</cite> [<a href="https://doi.org/10.1038/ncomms9018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4560751/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26292667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=Rare%20variant%20discovery%20by%20deep%20whole-genome%20sequencing%20of%201,070%20Japanese%20individuals&amp;author=M.%20Nagasaki&amp;author=J.%20Yasuda&amp;author=F.%20Katsuoka&amp;author=N.%20Nariai&amp;author=K.%20Kojima&amp;volume=6&amp;publication_year=2015&amp;pages=8018&amp;pmid=26292667&amp;doi=10.1038/ncomms9018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12-ijms-21-03895">
<span class="label">12.</span><cite>Higasa K., Miyake N., Yoshimura J., Okamura K., Niihori T., Saitsu H., Doi K., Shimizu M., Nakabayashi K., Aoki Y., et al.  Human genetic variation database, a reference database of genetic variations in the Japanese population. J. Hum. Genet. 2016;61:547–553. doi: 10.1038/jhg.2016.12.</cite> [<a href="https://doi.org/10.1038/jhg.2016.12" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4931044/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26911352/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Hum.%20Genet.&amp;title=Human%20genetic%20variation%20database,%20a%20reference%20database%20of%20genetic%20variations%20in%20the%20Japanese%20population&amp;author=K.%20Higasa&amp;author=N.%20Miyake&amp;author=J.%20Yoshimura&amp;author=K.%20Okamura&amp;author=T.%20Niihori&amp;volume=61&amp;publication_year=2016&amp;pages=547-553&amp;pmid=26911352&amp;doi=10.1038/jhg.2016.12&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13-ijms-21-03895">
<span class="label">13.</span><cite>Momozawa Y., Iwasaki Y., Parsons M.T., Kamatani Y., Takahashi A., Tamura C., Katagiri T., Yoshida T., Nakamura S., Sugano K., et al.  Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls. Nat. Commun. 2018;9:4083. doi: 10.1038/s41467-018-06581-8.</cite> [<a href="https://doi.org/10.1038/s41467-018-06581-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6172276/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30287823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=Germline%20pathogenic%20variants%20of%2011%20breast%20cancer%20genes%20in%207,051%20Japanese%20patients%20and%2011,241%20controls&amp;author=Y.%20Momozawa&amp;author=Y.%20Iwasaki&amp;author=M.T.%20Parsons&amp;author=Y.%20Kamatani&amp;author=A.%20Takahashi&amp;volume=9&amp;publication_year=2018&amp;pages=4083&amp;pmid=30287823&amp;doi=10.1038/s41467-018-06581-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14-ijms-21-03895">
<span class="label">14.</span><cite>Arai M., Yokoyama S., Watanabe C., Yoshida R., Kita M., Okawa M., Sakurai A., Sekine M., Yotsumoto J., Nomura H., et al.  Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: First report after establishment of HBOC registration system in Japan. J. Hum. Genet. 2018;63:447–457. doi: 10.1038/s10038-017-0355-1.</cite> [<a href="https://doi.org/10.1038/s10038-017-0355-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8716335/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29176636/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Hum.%20Genet.&amp;title=Genetic%20and%20clinical%20characteristics%20in%20Japanese%20hereditary%20breast%20and%20ovarian%20cancer:%20First%20report%20after%20establishment%20of%20HBOC%20registration%20system%20in%20Japan&amp;author=M.%20Arai&amp;author=S.%20Yokoyama&amp;author=C.%20Watanabe&amp;author=R.%20Yoshida&amp;author=M.%20Kita&amp;volume=63&amp;publication_year=2018&amp;pages=447-457&amp;pmid=29176636&amp;doi=10.1038/s10038-017-0355-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15-ijms-21-03895">
<span class="label">15.</span><cite>Hirotsu Y., Nakagomi H., Sakamoto I., Amemiya K., Mochizuki H., Omata M. Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing. Mol. Genet. Genom. Med. 2015;3:121–129. doi: 10.1002/mgg3.120.</cite> [<a href="https://doi.org/10.1002/mgg3.120" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4367084/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25802882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Genet.%20Genom.%20Med.&amp;title=Detection%20of%20BRCA1%20and%20BRCA2%20germline%20mutations%20in%20Japanese%20population%20using%20next-generation%20sequencing&amp;author=Y.%20Hirotsu&amp;author=H.%20Nakagomi&amp;author=I.%20Sakamoto&amp;author=K.%20Amemiya&amp;author=H.%20Mochizuki&amp;volume=3&amp;publication_year=2015&amp;pages=121-129&amp;pmid=25802882&amp;doi=10.1002/mgg3.120&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16-ijms-21-03895">
<span class="label">16.</span><cite>Cline M.S., Liao R.G., Parsons M.T., Paten B., Alquaddoomi F., Antoniou A., Baxter S., Brody L., Cook-Deegan R., Coffin A., et al.  BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2. PLoS Genet. 2018;14:e1007752.  doi: 10.1371/journal.pgen.1007752.</cite> [<a href="https://doi.org/10.1371/journal.pgen.1007752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6324924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30586411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genet.&amp;title=BRCA%20Challenge:%20BRCA%20Exchange%20as%20a%20global%20resource%20for%20variants%20in%20BRCA1%20and%20BRCA2&amp;author=M.S.%20Cline&amp;author=R.G.%20Liao&amp;author=M.T.%20Parsons&amp;author=B.%20Paten&amp;author=F.%20Alquaddoomi&amp;volume=14&amp;publication_year=2018&amp;pages=e1007752&amp;pmid=30586411&amp;doi=10.1371/journal.pgen.1007752&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17-ijms-21-03895">
<span class="label">17.</span><cite>Landrum M.J., Lee J.M., Riley G.R., Jang W., Rubinstein W.S., Church D.M., Maglott D.R. ClinVar: Public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:D980–D985. doi: 10.1093/nar/gkt1113.</cite> [<a href="https://doi.org/10.1093/nar/gkt1113" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3965032/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24234437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=ClinVar:%20Public%20archive%20of%20relationships%20among%20sequence%20variation%20and%20human%20phenotype&amp;author=M.J.%20Landrum&amp;author=J.M.%20Lee&amp;author=G.R.%20Riley&amp;author=W.%20Jang&amp;author=W.S.%20Rubinstein&amp;volume=42&amp;publication_year=2014&amp;pages=D980-D985&amp;pmid=24234437&amp;doi=10.1093/nar/gkt1113&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18-ijms-21-03895">
<span class="label">18.</span><cite>Nakagomi H., Mochizuki H., Inoue M., Hirotsu Y., Amemiya K., Sakamoto I., Nakagomi S., Kubota T., Omata M. Combined annotation-dependent depletion score for BRCA1/2 variants in patients with breast and/or ovarian cancer. Cancer Sci. 2018;109:453–461. doi: 10.1111/cas.13464.</cite> [<a href="https://doi.org/10.1111/cas.13464" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5797818/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29215753/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Sci.&amp;title=Combined%20annotation-dependent%20depletion%20score%20for%20BRCA1/2%20variants%20in%20patients%20with%20breast%20and/or%20ovarian%20cancer&amp;author=H.%20Nakagomi&amp;author=H.%20Mochizuki&amp;author=M.%20Inoue&amp;author=Y.%20Hirotsu&amp;author=K.%20Amemiya&amp;volume=109&amp;publication_year=2018&amp;pages=453-461&amp;pmid=29215753&amp;doi=10.1111/cas.13464&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19-ijms-21-03895">
<span class="label">19.</span><cite>Genomes Project C., Abecasis G.R., Auton A., Brooks L.D., DePristo M.A., Durbin R.M., Handsaker R.E., Kang H.M., Marth G.T., McVean G.A. An integrated map of genetic variation from 1,092 human genomes. Nature. 2012;491:56–65. doi: 10.1038/nature11632.</cite> [<a href="https://doi.org/10.1038/nature11632" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3498066/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23128226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=An%20integrated%20map%20of%20genetic%20variation%20from%201,092%20human%20genomes&amp;author=C.%20Genomes%20Project&amp;author=G.R.%20Abecasis&amp;author=A.%20Auton&amp;author=L.D.%20Brooks&amp;author=M.A.%20DePristo&amp;volume=491&amp;publication_year=2012&amp;pages=56-65&amp;pmid=23128226&amp;doi=10.1038/nature11632&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20-ijms-21-03895">
<span class="label">20.</span><cite>Lek M., Karczewski K.J., Minikel E.V., Samocha K.E., Banks E., Fennell T., O’Donnell-Luria A.H., Ware J.S., Hill A.J., Cummings B.B., et al.  Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536:285–291. doi: 10.1038/nature19057.</cite> [<a href="https://doi.org/10.1038/nature19057" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5018207/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27535533/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Analysis%20of%20protein-coding%20genetic%20variation%20in%2060,706%20humans&amp;author=M.%20Lek&amp;author=K.J.%20Karczewski&amp;author=E.V.%20Minikel&amp;author=K.E.%20Samocha&amp;author=E.%20Banks&amp;volume=536&amp;publication_year=2016&amp;pages=285-291&amp;pmid=27535533&amp;doi=10.1038/nature19057&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21-ijms-21-03895">
<span class="label">21.</span><cite>Karczewski K.J., Francioli L.C., Tiao G., Cummings B.B., Alföldi J., Wang Q., Collins R.L., Laricchia K.M., Ganna A., Birnbaum D.P., et al.  The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434–443. doi: 10.1038/s41586-020-2308-7.</cite> [<a href="https://doi.org/10.1038/s41586-020-2308-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7334197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32461654/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=The%20mutational%20constraint%20spectrum%20quantified%20from%20variation%20in%20141,456%20humans&amp;author=K.J.%20Karczewski&amp;author=L.C.%20Francioli&amp;author=G.%20Tiao&amp;author=B.B.%20Cummings&amp;author=J.%20Alf%C3%B6ldi&amp;volume=581&amp;publication_year=2020&amp;pages=434-443&amp;pmid=32461654&amp;doi=10.1038/s41586-020-2308-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22-ijms-21-03895">
<span class="label">22.</span><cite>Easton D.F., Deffenbaugh A.M., Pruss D., Frye C., Wenstrup R.J., Allen-Brady K., Tavtigian S.V., Monteiro A.N., Iversen E.S., Couch F.J., et al.  A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am. J. Hum. Genet. 2007;81:873–883. doi: 10.1086/521032.</cite> [<a href="https://doi.org/10.1086/521032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2265654/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17924331/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=A%20systematic%20genetic%20assessment%20of%201,433%20sequence%20variants%20of%20unknown%20clinical%20significance%20in%20the%20BRCA1%20and%20BRCA2%20breast%20cancer-predisposition%20genes&amp;author=D.F.%20Easton&amp;author=A.M.%20Deffenbaugh&amp;author=D.%20Pruss&amp;author=C.%20Frye&amp;author=R.J.%20Wenstrup&amp;volume=81&amp;publication_year=2007&amp;pages=873-883&amp;pmid=17924331&amp;doi=10.1086/521032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23-ijms-21-03895">
<span class="label">23.</span><cite>Mesman R.L.S., Calleja F., Hendriks G., Morolli B., Misovic B., Devilee P., van Asperen C.J., Vrieling H., Vreeswijk M.P.G. The functional impact of variants of uncertain significance in BRCA2. Genet. Med. 2019;21:293–302. doi: 10.1038/s41436-018-0052-2.</cite> [<a href="https://doi.org/10.1038/s41436-018-0052-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6752316/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29988080/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=The%20functional%20impact%20of%20variants%20of%20uncertain%20significance%20in%20BRCA2&amp;author=R.L.S.%20Mesman&amp;author=F.%20Calleja&amp;author=G.%20Hendriks&amp;author=B.%20Morolli&amp;author=B.%20Misovic&amp;volume=21&amp;publication_year=2019&amp;pages=293-302&amp;pmid=29988080&amp;doi=10.1038/s41436-018-0052-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24-ijms-21-03895">
<span class="label">24.</span><cite>Kobayashi Y., Yang S., Nykamp K., Garcia J., Lincoln S.E., Topper S.E. Pathogenic variant burden in the ExAC database: An empirical approach to evaluating population data for clinical variant interpretation. Genome Med. 2017;9:13. doi: 10.1186/s13073-017-0403-7.</cite> [<a href="https://doi.org/10.1186/s13073-017-0403-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5295186/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28166811/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Med.&amp;title=Pathogenic%20variant%20burden%20in%20the%20ExAC%20database:%20An%20empirical%20approach%20to%20evaluating%20population%20data%20for%20clinical%20variant%20interpretation&amp;author=Y.%20Kobayashi&amp;author=S.%20Yang&amp;author=K.%20Nykamp&amp;author=J.%20Garcia&amp;author=S.E.%20Lincoln&amp;volume=9&amp;publication_year=2017&amp;pages=13&amp;pmid=28166811&amp;doi=10.1186/s13073-017-0403-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25-ijms-21-03895">
<span class="label">25.</span><cite>Findlay G.M., Daza R.M., Martin B., Zhang M.D., Leith A.P., Gasperini M., Janizek J.D., Huang X., Starita L.M., Shendure J. Accurate classification of BRCA1 variants with saturation genome editing. Nature. 2018;562:217–222. doi: 10.1038/s41586-018-0461-z.</cite> [<a href="https://doi.org/10.1038/s41586-018-0461-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6181777/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30209399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Accurate%20classification%20of%20BRCA1%20variants%20with%20saturation%20genome%20editing&amp;author=G.M.%20Findlay&amp;author=R.M.%20Daza&amp;author=B.%20Martin&amp;author=M.D.%20Zhang&amp;author=A.P.%20Leith&amp;volume=562&amp;publication_year=2018&amp;pages=217-222&amp;pmid=30209399&amp;doi=10.1038/s41586-018-0461-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26-ijms-21-03895">
<span class="label">26.</span><cite>Kim H.K., Lee E.J., Lee Y.J., Kim J., Kim Y., Kim K., Lee S.W., Chang S., Lee Y.J., Lee J.W., et al.  Impact of proactive high-throughput functional assay data on BRCA1 variant interpretation in 3684 patients with breast or ovarian cancer. J. Hum. Genet. 2020;65:209–220. doi: 10.1038/s10038-019-0713-2.</cite> [<a href="https://doi.org/10.1038/s10038-019-0713-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31907386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Hum.%20Genet.&amp;title=Impact%20of%20proactive%20high-throughput%20functional%20assay%20data%20on%20BRCA1%20variant%20interpretation%20in%203684%20patients%20with%20breast%20or%20ovarian%20cancer&amp;author=H.K.%20Kim&amp;author=E.J.%20Lee&amp;author=Y.J.%20Lee&amp;author=J.%20Kim&amp;author=Y.%20Kim&amp;volume=65&amp;publication_year=2020&amp;pages=209-220&amp;pmid=31907386&amp;doi=10.1038/s10038-019-0713-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27-ijms-21-03895">
<span class="label">27.</span><cite>Lee M.S., Green R., Marsillac S.M., Coquelle N., Williams R.S., Yeung T., Foo D., Hau D.D., Hui B., Monteiro A.N., et al.  Comprehensive analysis of missense variations in the BRCT domain of BRCA1 by structural and functional assays. Cancer Res. 2010;70:4880–4890. doi: 10.1158/0008-5472.CAN-09-4563.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-09-4563" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3040717/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20516115/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=Comprehensive%20analysis%20of%20missense%20variations%20in%20the%20BRCT%20domain%20of%20BRCA1%20by%20structural%20and%20functional%20assays&amp;author=M.S.%20Lee&amp;author=R.%20Green&amp;author=S.M.%20Marsillac&amp;author=N.%20Coquelle&amp;author=R.S.%20Williams&amp;volume=70&amp;publication_year=2010&amp;pages=4880-4890&amp;pmid=20516115&amp;doi=10.1158/0008-5472.CAN-09-4563&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28-ijms-21-03895">
<span class="label">28.</span><cite>Nakamura S., Takahashi M., Tozaki M., Nakayama T., Nomizu T., Miki Y., Murakami Y., Aoki D., Iwase T., Nishimura S., et al.  Prevalence and differentiation of hereditary breast and ovarian cancers in Japan. Breast Cancer. 2015;22:462–468. doi: 10.1007/s12282-013-0503-1.</cite> [<a href="https://doi.org/10.1007/s12282-013-0503-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24249303/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer&amp;title=Prevalence%20and%20differentiation%20of%20hereditary%20breast%20and%20ovarian%20cancers%20in%20Japan&amp;author=S.%20Nakamura&amp;author=M.%20Takahashi&amp;author=M.%20Tozaki&amp;author=T.%20Nakayama&amp;author=T.%20Nomizu&amp;volume=22&amp;publication_year=2015&amp;pages=462-468&amp;pmid=24249303&amp;doi=10.1007/s12282-013-0503-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29-ijms-21-03895">
<span class="label">29.</span><cite>Hart S.N., Hoskin T., Shimelis H., Moore R.M., Feng B., Thomas A., Lindor N.M., Polley E.C., Goldgar D.E., Iversen E., et al.  Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models. Genet. Med. 2019;21:71–80. doi: 10.1038/s41436-018-0018-4.</cite> [<a href="https://doi.org/10.1038/s41436-018-0018-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6287763/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29884841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=Comprehensive%20annotation%20of%20BRCA1%20and%20BRCA2%20missense%20variants%20by%20functionally%20validated%20sequence-based%20computational%20prediction%20models&amp;author=S.N.%20Hart&amp;author=T.%20Hoskin&amp;author=H.%20Shimelis&amp;author=R.M.%20Moore&amp;author=B.%20Feng&amp;volume=21&amp;publication_year=2019&amp;pages=71-80&amp;pmid=29884841&amp;doi=10.1038/s41436-018-0018-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30-ijms-21-03895">
<span class="label">30.</span><cite>Lee J.S., Oh S., Park S.K., Lee M.H., Lee J.W., Kim S.W., Son B.H., Noh D.Y., Lee J.E., Park H.L., et al.  Reclassification of BRCA1 and BRCA2 variants of uncertain significance: A multifactorial analysis of multicentre prospective cohort. J. Med. Genet. 2018;55:794–802. doi: 10.1136/jmedgenet-2018-105565.</cite> [<a href="https://doi.org/10.1136/jmedgenet-2018-105565" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30415210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=Reclassification%20of%20BRCA1%20and%20BRCA2%20variants%20of%20uncertain%20significance:%20A%20multifactorial%20analysis%20of%20multicentre%20prospective%20cohort&amp;author=J.S.%20Lee&amp;author=S.%20Oh&amp;author=S.K.%20Park&amp;author=M.H.%20Lee&amp;author=J.W.%20Lee&amp;volume=55&amp;publication_year=2018&amp;pages=794-802&amp;pmid=30415210&amp;doi=10.1136/jmedgenet-2018-105565&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31-ijms-21-03895">
<span class="label">31.</span><cite>So M.K., Jeong T.D., Lim W., Moon B.I., Paik N.S., Kim S.C., Huh J. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines. Breast Cancer. 2019 doi: 10.1007/s12282-019-00951-w.</cite> [<a href="https://doi.org/10.1007/s12282-019-00951-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30725392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer&amp;title=Reinterpretation%20of%20BRCA1%20and%20BRCA2%20variants%20of%20uncertain%20significance%20in%20patients%20with%20hereditary%20breast/ovarian%20cancer%20using%20the%20ACMG/AMP%202015%20guidelines&amp;author=M.K.%20So&amp;author=T.D.%20Jeong&amp;author=W.%20Lim&amp;author=B.I.%20Moon&amp;author=N.S.%20Paik&amp;publication_year=2019&amp;pmid=30725392&amp;doi=10.1007/s12282-019-00951-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32-ijms-21-03895">
<span class="label">32.</span><cite>Mondal G., Rowley M., Guidugli L., Wu J., Pankratz V.S., Couch F.J. BRCA2 localization to the midbody by filamin A regulates cep55 signaling and completion of cytokinesis. Dev. Cell. 2012;23:137–152. doi: 10.1016/j.devcel.2012.05.008.</cite> [<a href="https://doi.org/10.1016/j.devcel.2012.05.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3419138/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22771033/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Dev.%20Cell&amp;title=BRCA2%20localization%20to%20the%20midbody%20by%20filamin%20A%20regulates%20cep55%20signaling%20and%20completion%20of%20cytokinesis&amp;author=G.%20Mondal&amp;author=M.%20Rowley&amp;author=L.%20Guidugli&amp;author=J.%20Wu&amp;author=V.S.%20Pankratz&amp;volume=23&amp;publication_year=2012&amp;pages=137-152&amp;pmid=22771033&amp;doi=10.1016/j.devcel.2012.05.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33-ijms-21-03895">
<span class="label">33.</span><cite>Guidugli L., Carreira A., Caputo S.M., Ehlen A., Galli A., Monteiro A.N., Neuhausen S.L., Hansen T.V., Couch F.J., Vreeswijk M.P., et al.  Functional assays for analysis of variants of uncertain significance in BRCA2. Hum. Mutat. 2014;35:151–164. doi: 10.1002/humu.22478.</cite> [<a href="https://doi.org/10.1002/humu.22478" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3995136/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24323938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Functional%20assays%20for%20analysis%20of%20variants%20of%20uncertain%20significance%20in%20BRCA2&amp;author=L.%20Guidugli&amp;author=A.%20Carreira&amp;author=S.M.%20Caputo&amp;author=A.%20Ehlen&amp;author=A.%20Galli&amp;volume=35&amp;publication_year=2014&amp;pages=151-164&amp;pmid=24323938&amp;doi=10.1002/humu.22478&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34-ijms-21-03895">
<span class="label">34.</span><cite>Balia C., Galli A., Caligo M.A. Effect of the overexpression of BRCA2 unclassified missense variants on spontaneous homologous recombination in human cells. Breast Cancer Res. Treat. 2011;129:1001–1009. doi: 10.1007/s10549-011-1607-y.</cite> [<a href="https://doi.org/10.1007/s10549-011-1607-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21671020/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat&amp;title=Effect%20of%20the%20overexpression%20of%20BRCA2%20unclassified%20missense%20variants%20on%20spontaneous%20homologous%20recombination%20in%20human%20cells&amp;author=C.%20Balia&amp;author=A.%20Galli&amp;author=M.A.%20Caligo&amp;volume=129&amp;publication_year=2011&amp;pages=1001-1009&amp;pmid=21671020&amp;doi=10.1007/s10549-011-1607-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35-ijms-21-03895">
<span class="label">35.</span><cite>Starita L.M., Islam M.M., Banerjee T., Adamovich A.I., Gullingsrud J., Fields S., Shendure J., Parvin J.D. A Multiplex Homology-Directed DNA Repair Assay Reveals the Impact of More Than 1,000 BRCA1 Missense Substitution Variants on Protein Function. Am. J. Hum. Genet. 2018;103:498–508. doi: 10.1016/j.ajhg.2018.07.016.</cite> [<a href="https://doi.org/10.1016/j.ajhg.2018.07.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6174279/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30219179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=A%20Multiplex%20Homology-Directed%20DNA%20Repair%20Assay%20Reveals%20the%20Impact%20of%20More%20Than%201,000%20BRCA1%20Missense%20Substitution%20Variants%20on%20Protein%20Function&amp;author=L.M.%20Starita&amp;author=M.M.%20Islam&amp;author=T.%20Banerjee&amp;author=A.I.%20Adamovich&amp;author=J.%20Gullingsrud&amp;volume=103&amp;publication_year=2018&amp;pages=498-508&amp;pmid=30219179&amp;doi=10.1016/j.ajhg.2018.07.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36-ijms-21-03895">
<span class="label">36.</span><cite>Brnich S.E., Rivera-Muñoz E.A., Berg J.S. Quantifying the potential of functional evidence to reclassify variants of uncertain significance in the categorical and Bayesian interpretation frameworks. Hum. Mutat. 2018;39:1531–1541. doi: 10.1002/humu.23609.</cite> [<a href="https://doi.org/10.1002/humu.23609" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6548460/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30095857/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Quantifying%20the%20potential%20of%20functional%20evidence%20to%20reclassify%20variants%20of%20uncertain%20significance%20in%20the%20categorical%20and%20Bayesian%20interpretation%20frameworks&amp;author=S.E.%20Brnich&amp;author=E.A.%20Rivera-Mu%C3%B1oz&amp;author=J.S.%20Berg&amp;volume=39&amp;publication_year=2018&amp;pages=1531-1541&amp;pmid=30095857&amp;doi=10.1002/humu.23609&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37-ijms-21-03895">
<span class="label">37.</span><cite>Hirotsu Y., Ooka Y., Sakamoto I., Nakagomi H., Omata M. Simultaneous detection of genetic and copy number alterations in BRCA1/2 genes. Oncotarget. 2017;8:114463–114473. doi: 10.18632/oncotarget.22962.</cite> [<a href="https://doi.org/10.18632/oncotarget.22962" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5777706/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29383094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Simultaneous%20detection%20of%20genetic%20and%20copy%20number%20alterations%20in%20BRCA1/2%20genes&amp;author=Y.%20Hirotsu&amp;author=Y.%20Ooka&amp;author=I.%20Sakamoto&amp;author=H.%20Nakagomi&amp;author=M.%20Omata&amp;volume=8&amp;publication_year=2017&amp;pages=114463-114473&amp;pmid=29383094&amp;doi=10.18632/oncotarget.22962&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7312854/bin/ijms-21-03895-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (1.5MB, zip) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from International Journal of Molecular Sciences are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3390/ijms21113895"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/ijms-21-03895.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (6.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/7312854/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/7312854/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7312854%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7312854/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC7312854/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC7312854/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/32486089/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC7312854/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/32486089/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC7312854/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/7312854/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="26LT7YHFszcSuf0wKZhcOqkLtWeWM8Q3Egb6TQadJhGcFlvx0YFMlydrAOD9PTly">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
